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Background: Tourette Syndrome (TS) appears to be an inherited disorder, although genetic abnormalities have
been identified in less than 1% of patients, and the mode of inheritance is uncertain. Many studies have
investigated environmental factors that might contribute to the onset and severity of tics and associated
comorbidities such as obsessive compulsive disorder (OCD) and attention deficit hyperactive disorder (ADHD).
A systematic review and qualitative analysis were performed to provide a broad view of the association between
pre- and perinatal factors and TS.
Methods: The Medline, Embase and PsycINFO databases were searched using terms specific to Tourette’s
syndrome and keywords such as “pregnancy”, “prenatal”, “perinatal”, “birth” and “neonatal”. Studies were limited to
studies on human subjects published in English or French through October 2012.
Results: 22 studies were included. Studies were of limited methodological quality, with most samples derived from
specialty clinics, and most exposures ascertained retrospectively. The majority of the results for demographic factors
of parents, including age, education, socioeconomic status, and marital status, revealed no significant association
with the onset of TS, or the presence of comorbidity. Many factors were reported to be significantly associated with
the onset of TS, the presence of comorbidity and symptom severity, but the most consistently reported factors
were maternal smoking and low birth weight.
Conclusions: There are few studies evaluating the relationship between pre and perinatal events and TS, and
existing studies have major limitations, including the use of clinic rather than epidemiologically derived samples,
retrospective data collection on pre and perinatal events and multiple hypothesis testing without appropriate
statistical correction. The mechanism by which prenatal and perinatal adversities could lead to TS onset or
symptom severity is unknown, but may be related to changes in the dopaminergic system as a result of early brain
injury.
Keywords: Tourette syndrome, Tic disorders, Prenatal morbidity, Risk factorsBackground
Tourette Syndrome (TS) appears to be an inherited dis-
order, although genetic abnormalities have been identi-
fied in less than 1% of patients, and the exact mode of
inheritance has not been determined [1]. Some genetic
studies have reported infrequent associations of specific
genes with TS, including the mutation of SLITRK1 encod-
ing SLIT and NTRK-like protein 1 and a rare functional* Correspondence: tmprings@ucalgary.ca
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reproduction in any medium, provided the ormutation in the HDC gene encoding L-histidine decarb-
oxylase [2-9]. While current research suggests that genetic
factors confer the greatest risk for the development of TS,
many studies have investigated environmental factors
that might contribute to the onset of TS, associated co-
morbidities and more severe symptoms. Among these en-
vironmental factors, many studies report that pre- and
perinatal factors may play an important role in the patho-
genesis of TS [10-28]. However, analysis of these studies
has revealed inconsistent results.
We performed a systematic review to gain a complete per-
spective on the association between pre- and peri-natal ad-
versities and TS, including the onset of symptoms, symptomtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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There are no up to date systematic reviews focusing on
this issue. In this article, a systematic review and qualita-
tive analysis were performed to provide a broad view of
the association between pre- and perinatal factors and TS.
Methods
Electronic searches and selection of studies
The Medline, Embase and PsycINFO databases were
searched using terms specific to Tourette’s syndrome and
keywords such as “pregnancy”, “prenatal”, “perinatal”,
“birth” and “neonatal” (Additional file 1). Studies were
limited to studies on human subjects published in English
or French through October 2012. Two reviewers inde-
pendently screened the titles and abstracts. Review ar-
ticles, commentary articles, editorials, animal studies,
and case-reports were excluded. Potentially relevant
articles for full-text review were identified by reading
abstracts and titles. Full text review was performed
on any study for which the abstract or title suggested
that the study evaluated pre or perinatal risk factors
associated with the development of TS or related to TS se-
verity. Disagreements were resolved by consensus between
the two reviewers. Full texts of the selected articles were
further reviewed and the following criteria were used to
include articles for data extraction: 1) studies specific fac-
tors in the prenatal and perinatal period 2) evaluates asso-
ciation with the diagnosis or symptom severity of Tourette
syndrome or its comorbidities 3) original study with fully
published article available.
Data extraction
The following information was extracted onto piloted
forms: 1) First author, year and geographic location of
the study 2) case definition and ascertainment, sources
and numbers of cases and controls, matching factors
3) severity scales for Tourette’s syndrome or its comor-
bidities 4) specific risk factors 5) study results, including
risk estimate and indicators of statistical significance.
Results
The electronic searches yielded 141 abstracts, with 31
abstracts selected for full-text review [10-40]. After full
text review of these 31 articles, 9 were excluded be-
cause only case series were studied [31,32,35,37,38], only
poster abstract was available [33], or the contents didn’t
include pre- or peri-natal adversities [10,34,40]. Because
of the extreme diversities among studies, the included 22
articles were further categorized according to the different
purpose, study design, investigated factors, and outcome.
In these 22 articles, two of them were duplicates of data
[11,14]. Therefore, the data in one report was selected ac-
cording to the completeness of data contained in both re-
ports [11] (see Figure 1).Of the 21 studies reporting original data, three were
prospective cohort studies, nine were case control stud-
ies, four were single group cross sectional studies evalu-
ating disease severity, one was a cross-sectional study
with matched case–control pairs, three were twin or
family studies, and one was a multiple case group com-
parative study. The three prospective cohort studies col-
lected pre- and perinatal data prospectively. Two case
control studies used pre- and perinatal data recorded on
registered birth certificates at the time of delivery, and
one cross-sectional study examined children for minor
physical anomalies. The remaining fifteen studies col-
lected pre- and perinatal risk factor data retrospectively
through parental interview. With the exception of the
three prospective cohort studies and one case control
study, all samples of cases were derived from speciality
clinic settings. See Table 1 for information on study de-
sign, sources of cases and controls, data collection and
risk factors studied.
Studies investigating the association between pre- and
perinatal factors and the onset of Tourette syndrome,
and/or risk of comorbidity
There were 14 articles investigating individual pre- or peri-
natal factors associated with the onset of TS, risk for co-
morbidities such as ADHD or OCD, or different genders
in TS [11-23]. The summarized results are shown in
Table 2. Because of diverse methods for measurement of
the risk factors among studies, the results are presented ac-
cording to the original definition by each study. Similar fac-
tors were grouped together but quantitative summarization
was not possible because of small sample sizes and the di-
versity of studies.
Demographic factors and pre-conception health status
In Table 2, the majority of the results for demographic
factors of parents, including age, education, socioeco-
nomic status, and marital status, revealed no significant
association with the onset of TS, or the presence of TS
comorbidity such as ADHD [11,13,14,17,20]. There was
only one small study (25 cases and 25 controls) in which
the mother’s age in the group with TS was significantly
younger than the control group (20 ± 1.4 versus 23 ± 3.4,
p < 0.01) [13]. For pre-conception health status, major
health problems prior to pregnancy were not associated
with the onset of TS, or TS comorbidity, according to
the results of two published studies [15,17].
Prenatal period
During the prenatal period, many studies found that
some prenatal adversities were significantly associated
with the onset of TS or comorbidities, although the re-
sults were not consistent (Table 2). Burd (1999) reported
that TS was associated with earlier prenatal care and
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Figure 1 PRISMA flow diagram of included studies.
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One cross sectional study evaluating the association be-
tween minor physical anomalies and TS suggested that
early insults during pregnancy might be associated with
the onset of TS, as children with TS had a significantly
higher number of minor physical anomalies [12]. In 4
studies investigating the association between pregnancy
complications and TS onset, the presence of comorbid-
ity, or gender, one study showed a borderline association
of one or more pregnancy complications with TS onset
(OR = 2.33, 95% CI = 0.92-5.89, p = 0.069) [18]. Another
study demonstrated that one or more pregnancy compli-
cations were significantly associated with TS with co-
morbid ADHD compared to controls, but not associated
with TS only patients [17]. One study found that the
overall number of prenatal problems was associated with
a higher risk of ADHD comorbidity (OR = 2.97, 95% CI:
1.27-6.94, p = 0.02) [26].Some individual and combined factors during pregnancy
were also investigated, including maternal hypertension,
psychosocial stress, antibiotic exposure, or medications/
procedures [17,19,21]. In these studies, psychosocial stress
was not significantly associated with the onset of TS or TS
with ADHD compared to controls. In another study, anti-
biotic exposure was significantly associated with both TS
and TS with ADHD (p = 0.02) [17].
With regard to maternal smoking, one study revealed
borderline results in the association with onset of TS or
TS with ADHD compared to the control group. The
odds ratios were very high: TS (OR = 4.6), TS with
ADHD (OR = 8.5) (Table 2) [17]. The study found that
TS with ADHD had an even higher association with
maternal smoking than TS only. This trend was also
noted in another study- that compared to TS only pa-
tients, the presence of ADHD comorbidity was signifi-
cantly associated with maternal smoking during the
Table 1 Characteristics of included studies
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Table 1 Characteristics of included studies (Continued)
Motlagh 2010
[17]
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Table 2 Pre- and peri-natal factors associated with the onset of Tourette’s syndrome (TS), and the presence of comorbidity




Mother's age 25.69 (5.29) vs. 25.12 (5.2) p = 0.33 92 460 Matched analysis Burd 1999 [11]
20 (1.4) vs. 23 (3.4) p < 0.01 25 25 Khalifa 2005 [13]
29.8 (4.5) vs. 29.6 66 1174999 Adjusted for birth
year
Shimada 2012 [20]
TS: 28.9 (4.4), TS + ADHD: 28.1 (5.3), Control:
28.3 (4.1)
NS TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
Father's age 28.87 (6.25) vs. 27.78 (5.96) p = 0.11 92 460 Matched analysis Burd 1999 [11]
31.9 (5.0) vs. 32.7 NS 65 1174999 Adjusted for birth
year
Shimada 2012 [20]
TS: 30.9 (5.0), TS + ADHD: 30.2 (6.2), Control:
30.4 (5.0)
NS TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
Mother's education 12.90 (2.11) vs. 12.64 (1.92) p = 0.24 92 460 Matched analysis Burd 1999 [11]
Father's education 12.69 (2.44) vs. 12.67 (2.15) p = 0.96 92 460 Matched analysis Burd 1999 [11]
Parent's education TS: 15.5 (2.0), TS + ADHD: 14.9 (1.8), Control:
15.3 (2.0)
NS TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
Mean socioeconomic status TS: 50.4 (2.7), TS + ADHD: 47.4 (10.6), Control:
48.5 (10.7)
NS TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
Socio-economic status, parental
education or divorce rate
No difference (no data provided) NS 25 25 Khalifa 2005 [13]
Marital status 4/92 vs. 36/460 p = 0.93 92 460 Klug 2003 [14]
Pre-conception condition
Major diseases before pregnancy
or pre-existing medical conditions
(20/42 vs. 21/43) OR = 0.95, 95% CI = 0.41-2.23 p = 0.91 42 43 Kondo 1982 [15]
TS vs. Control (1/45 vs. 4/65); TS + ADHD vs.
Control (4/60 vs. 4/65)
NS TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
Pre-natal period
Month prenatal care began 2.47 (1.27) vs. 3.01 (1.40) p = 0.001 92 460 Matched analysis Burd 1999 [11]
Prenatal visits 10.00 (3.57) vs. 8.51 (3.22) p < 0.001 92 460 Matched analysis Burd 1999 [11]
Prenatal care begun after first trimester OR = 0.49 (0.27-0.90), (14/92 vs. 123/460) p = 0.03 92 460 Burd 1999 [11]
Minor physical anomalies (numbers) 5.46 (2.15) vs. 1.11(1.18); Mann–Whitney U-test
49.50, -Z = −4.92
p = 0.001 24 24 Csabi 2008 [12]
Number of prenatal problems Presence of ADHD, OR = 2.97, 95% CI: 1.27-6.94 p = 0.02 180 Mathews 2006 [26]
Disordered pregnancies (12/42 vs. 15/43) OR = 0.75, 95% CI = 0.30-1.87 p = 0.53 42 43 Kondo 1982 [15]
Any pregnancy complication Male TS vs. Female TS: 63% vs. 83% NS 46 M 7 F Santangelo 1994 [19]




















Table 2 Pre- and peri-natal factors associated with the onset of Tourette’s syndrome (TS), and the presence of comorbidity (Continued)
One or more pregnancy complication 17/51 vs. 9/51 (OR = 2.33, 95% CI = 0.92-5.89) p = 0.07 51 51 Pasamanick 1956
[18]
TS + ADHD: 27/60, Control: 16/65 p = 0.01 TS + ADHD:60 65 Motlagh 2010 [17]
TS: 17/45, Control: 16/65 NS TS: 45 65 Motlagh 2010 [17]
Maternal hypertension TS + ADHD vs. TS, OR = 1.04 (95% CI: 0.44-2.42) p = 0.93 181 172 Unadjusted OR Pringsheim 2009 [21]
Severe psychosocial stress TS vs. Control (10/45 vs. 5/62, OR = 2.6, 95%
CI = 0.08-8.7, p = 0.11); TS + ADHD vs. Control
(11/55 vs. 5/62, OR = 3.1, 95% CI = 0.9-11.1,
p = 0.07)
p = 0.11 and
0.07





Antibiotics exposure in pregnancy TS: 11/45, TS + ADHD: 11/60, Control: 6/65 both p < 0.05 TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
Medication/procedures Male TS vs. Female TS: 37% vs. 50% NS 46 M 7 F Santangelo 1994 [19]
TS + OCD vs. TS: 27% vs. 44% NS 15 34 Santangelo 1994 [19]
Number of medications exposed to in utero Presence of ADHD, OR = 0.50, 95% CI: 0.25-1.00 p < 0.05 180 Mathews 2006 [26]
Maternal smoking (>10 cigarettes/d) TS vs. Control (3/45 vs. 1/62, OR = 4.6, 95%
CI = 0.45-46.6, p = 0.19); TS + ADHD vs. Control
(7/60 vs. 1/62, OR = 8.5, 95% CI = 0.97-75.2,
p = 0.052)
p = 0.19 and
0.05





Maternal smoking TS + ADHD vs. TS, OR = 2.43 (95% CI: 1.23-4.82) p = 0.01 181 172 Adjusted OR Pringsheim 2009 [21]
Maternal smoking Presence of OCD (OR = 8.27, 95% CI = 0.87-78.20) p = 0.07 180 Mathews 2006 [26]
Maternal alcohol exposure TS + ADHD vs. TS, OR = 0.81 (95% CI: 0.46-1.41) p = 0.45 181 172 Adjusted OR Pringsheim 2009 [21]
Coffee, cigarettes, alcohol Male TS vs. Female TS: 47% vs. 50% NS 46 M 7 F Santangelo 1994 [19]
TS + OCD vs. TS: OR = 5.0, 95% CI: 1.3-19.4 p < 0.05 15 34 Santangelo 1994 [19]
Perinatal period
Disordered deliveries (16/42 vs. 14/43) (OR = 1.27, 95% CI = 0.52-3.11) p = 0.59 42 43 Kondo 1982 [15]
Any delivery complication Male TS vs. Female TS: OR = 9.4, 95% CI: 1.01-87.3 p < 0.05 46 M 7 F Santangelo 1994 [19]
TS + OCD vs. TS: 75% vs. 54% NS 15 34 Santangelo 1994 [19]
Operative delivery TS + ADHD vs. TS, OR = 1.10 (95% CI: 0.71-1.71) p = 0.66 181 172 Unadjusted OR Pringsheim 2009 [21]
Forceps delivery Male TS vs. Female TS: 44% vs. 14% NS 46 M 7 F Santangelo 1994 [19]
TS + OCD vs. TS: OR = 7.9, 95% CI: 3.2-19.5 p < 0.01 15 34 Santangelo 1994 [19]
Perinatal disorders: low BW, Asphyxia, severe
vomiting, cyanosis, respiratory distress, jaundice,
convulsion, high fever, incubator using, exchange
transfusion
8/43 vs. 9/43, X^2 = 0.07 (OR = 0.86, 95%
CI = 0.30-2.50)




















Table 2 Pre- and peri-natal factors associated with the onset of Tourette’s syndrome (TS), and the presence of comorbidity (Continued)
Perinatal complications (postnatal jaundice, cord
around neck, breech birth, premature birth)
TS + OCS vs. TS only: 5/13 vs. 0/10) p < 0.01 13 10 Fisher's exact test Iida 1996 [22]
> 1 hypoxic event TS vs. Control (17/45 vs. 18/65, OR = 1.4, 95%
CI = 0.64-3.3, NS); TS + ADHD vs. Control
(18/60 vs. 18/65, OR = 0.9, 95% CI = 0.4-2.2, NS)





Apgar 1 7.170+/−1.909 vs. 7.517+/−1.623 p = 0.17 53 265 Matched analysis Burd 1999 [11]
Apgar 5 8.396+/−1.446 vs.8.789+/−1.123 p = 0.03 53 265 Matched analysis Burd 1999 [11]
Breathing problems at birth TS + ADHD vs. TS, OR = 1.95 (95% CI: 0.87-4.37) p = 0.10 181 172 Adjusted OR Pringsheim 2009 [21]
Combined pre- and peri-natal periods
Total with abnormalities of prenatal and perinatal
periods
19/51 vs. 13/51 (OR = 1.74, 95% CI = 0.74-4.05) p = 0.20 51 51 Pasamanick 1956 [18]
Reduced optimality in pre-, peri-, and neonatal
periods
No statistical differences between cases and
controls (no data provided) in reduced optimality
25 25 Khalifa 2005 [13]
Pre- and perinatal events TS (26/48 (54%)), Chronic tics (24/48 (50%)) vs.
Control (2/30 (6%)); TS: OR = 16.55 (95%






30 Saccomani 2005 [23]
Neonatal factors
Gestation age 39.64 (2.73) vs. 40.04 (3.54) 0.44 92 460 Matched analysis Burd 1999 [11]
Gestational age (<37 week) 5/106 vs. 62289/1153363 106 1153363 Shimada 2012 [20]
TS + ADHD vs. TS, OR = 3.83 (95% CI: 15.1-9.69) p < 0.01 181 172 Unadjusted OR Pringsheim 2009 [21]
Gestational age (<38 week) TS: 1/45, TS + ADHD: 6/60, Control: 7/65 NS TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
Gestational age (>42 week) TS: 4/45, TS + ADHD: 4/60, Control: 2/65 NS TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
Birth Weight 3342.2+/− 661.38 vs. 3447.7+/−607.71 p = 0.14 92 460 Matched analysis Burd 1999 [11]
TS: 3538+/−530, TS + ADHD: 3438+/−538,
Control: 3519+/−755
NS TS: 45, TS +
ADHD:60
65 Motlagh 2010 [17]
TS vs. Disconcordant Twin: 2228 + −244 vs.
2545 + −216
p = 0.006 6 6 Twins study
(paired t test)
Leckman 1987 [16]
Low birth weight (<2500 g) TS vs. Control (1/45 vs. 2/65, OR = 1.3, 95%
CI = 0.11-15.4, NS); TS + ADHD vs. Control
(3/57 vs. 2/65, OR = 0.55, 95%
CI = 0.08-3.7, NS)





TS vs. Control (1/116 vs. 9162/100097, OR = 0.094) 116 100097 Shimada 2012 [20]
TS + ADHD vs. TS, OR = 2.74 (95% CI: 1.03-7.29) p = 0.04 181 172 Adjusted OR Pringsheim 2009 [21]




















Table 2 Pre- and peri-natal factors associated with the onset of Tourette’s syndrome (TS), and the presence of comorbidity (Continued)
Birth weight above 2500 g Presence of ADHD, OR = 0.69, 95% CI: 0.52-0.92 p = 0.02 180 Mathews 2006 [26]
Birth order X^2 = 2.53 NS 43 43 Kondo 1982 [15]
First (78/116 vs. 53947/100118), second (34/116 vs.
34594/100118), > = third (8/116 vs. 11577/100118)
116 100118 Shimada 2012 [20]
*TS versus controls if not indicated. ADHD: Attention deficit hyperactive disorder; BW: birth weight; CI: confidence interval; NS: non-significant; OCD: Obsessive compulsive disorder; OCS: Obsessive compulsive
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p = 0.01) [21]. Maternal smoking was also reported to
be associated with a borderline higher risk for OCD
(OR = 8.27, 95% CI = 0.87-78.20, p = 0.07) [26]. In an-
other study combining coffee, cigarettes, and alcohol
exposures as one single factor, the presence of comorbid
OCD with TS was significantly associated with these ex-
posures compared to TS only patients (OR = 5.0, 95%
CI: 1.3-19.4, p < 0.05) [19].
In summary, although there were no consistent re-
sults among studies, many factors were reported to be
significantly associated with the onset of TS or the
presence of comorbidities in TS patients. These factors
included earlier prenatal care, more prenatal visits,
pregnancy complications, antibiotic exposure, maternal
smoking, and coffee, cigarette, and alcohol exposure. Pre-
natal adversities during a critical developmental stage
may be associated with the onset of TS or the develop-
ment of comorbidities in these patients.Perinatal period
The association between TS and perinatal risk factors
was reported in 6 articles (Table 2) [11,15,17,19,21,22].
These studies suggest that while some perinatal risk
factors were associated with specific conditions, the re-
sults are inconsistent. Among them, delivery complica-
tions were noted more frequently in boys with TS
compared to girls (OR = 9.4, 95% CI: 1.01-87.3, p <
0.05) [19]. Forceps delivery was associated with the
presence of OCD in TS patients compared to TS only
(OR = 7.9, 95% CI: 3.2-19.5, p < 0.01) [19]. In addition,
Iida reported that perinatal complications were associ-
ated with the presence of obsessive-compulsive symp-
toms in TS patients compared to TS only [22]. For the
onset of TS, Burd et al. (1999) reported that the Apgar
score at 5 minutes was significantly lower in children
with TS compared to controls (8.396 ± 1.446 vs. 8.789 ±
1.123, p = 0.028) [11]. Although significant associations
between TS and the perinatal factors described above
were reported in these 6 articles, many of these articles
revealed non-significant results for different measure-
ments. Compared to prenatal factors, a relatively smaller
proportion of results for perinatal factors revealed sig-
nificant associations with TS.Combined prenatal and perinatal period
When prenatal and perinatal adversities were considered
as one factor, only one of 3 studies revealed significant
associations of prenatal and perinatal adversity with TS
(OR = 16.55, 95%CI = 3.54-77.40, p < 0.001) or chronic tics
(OR = 14.00 95%CI = 3.00-65.44, p < 0.001) (Table 2) [23].
However, in the other two studies, no associations were
reported [13,18].Neonatal factors
The relationship between gestational age, birth weight,
birth order and TS has been investigated in several studies
(Table 2) [11,15-17,20,21]. Most studies reported non-
significant results for these factors. In 4 articles investigat-
ing gestational age, only one study revealed that the pres-
ence of ADHD in TS patients was significantly associated
with prematurity (<37 weeks) compared to TS only pa-
tients in an unadjusted evaluation (OR = 3.83, 95% CI:
15.1-9.69, p < 0.01) [21]. The same study also found that
low birth weight (<2500 g) was associated with a higher
odds of comorbid TS and ADHD (OR = 2.74, 95% CI:
1.03-7.29, p = 0.04) [21]. Another study found that higher
birth weight was associated with a lower risk of ADHD
comorbidity in TS patients (OR = 0.69, 95% CI: 0.52-0.92,
p = 0.02) [26]. In a twin study where only one twin was af-
fected by TS, lower birth weight was noted in the TS twin
compared to their disconcordant twin without TS (TS
twins: 2228 ± 244 gm vs. Twins without TS: 2545 ± 216
gm, paired t test, p = 0.006) [16]. For birth order, both
studies found that it is not associated with the onset of
TS [15,20].Studies investigating the association between pre- and
perinatal factors and severity of tic symptoms and
comorbidities
There were 5 articles investigating the association between
pre- and perinatal factors and the severity of tic symptoms
and comorbidities [24-28]. All articles included only TS
patients using a single group cross sectional design with
comparison of disease symptom severity between those
exposed and not exposed to perinatal adversity. All of the
significant and non-significant results in these articles
were summarized in Table 3.Prenatal factors
Some prenatal factors were reported to be significantly as-
sociated with the severity of tic symptoms or comorbidities
(Table 3). Pregnancy complications which included hyper-
tension, infections, (pre)eclampsia, psychosocial stress, or
diabetes mellitus were reported to be associated with
greater tic severity at a single time point as measured by
the Yale Global Tic Severity Scale (YGTSS) [27]. How-
ever, these pregnancy complications were found to be
associated with lower mean compulsive CYBOCS rat-
ings in these patients [28]. In addition, severity of nau-
sea/vomiting during pregnancy was also noted to be
associated with current tic severity as measured using
the TS Global Scale based on all available information
(direct examination, review of videotapes, parental- and
self-reports, school reports, and medical records) [24].
With respect to in utero medication exposure, this was
associated with global tic severity and a borderline higher
Table 3 Pre and perinatal factors associated with tic severity and severity of co-morbid ADHD, OCD, and other disorders








Pregnancy complications Current YGTSS 22.3+/−9.4 vs. 17.3+/−8.4 p = 0.03 ↑ 70 YGTSS Bos-Veneman 2010
[27]
2.0 + −3.7 vs. 3.9 + −4.9 p = 0.05 ↓ 110 CYBOCS Bos-Veneman 2010
[27]
No difference in worst ever tic severity p = 0.68 - 70 YGTSS Bos-Veneman 2010
[27]
No difference in ADHD severity p = 0.45 - 65 ADHD rating scale Bos-Veneman 2010
[27]
No difference in tic severity NS - 110 YGTSS Bos-Veneman 2010
[27]
No difference in social behaviours NS - 110 CSBQ Bos-Veneman 2010
[27]
No difference in anxiety and depression NS - 110 RCADS Bos-Veneman 2010
[27]




Number of medications exposed in utero Associated with increased global tic severity p < 0.00001 ↑ 180 YGTSS Mathews 2006 [26]
Interference of OCS p = 0.08 ↑ 180 Mathews 2006 [26]
Maternal smoking ADHD Severity 26.4 + −10.1 vs. 19.1 + −10.9 p = 0.05 ↑ 70 ADHD rating scale Bos-Veneman 2010
[27]
Associated with more severe ADHD
symptoms modified by positive family
history of mental disorders
p = 0.04 ↑ 70 ADHD rating scale Bos-Veneman 2010
[27]
9.1 + −4.1 vs. 6.1 + −4.1 p = 0.05 ↑ 110 MDD RCADS Bos-Veneman 2010
[27]




Positive association with tic severity p < 0.00001 ↑ 180 YGTSS Mathews 2006 [26]
Interference of OCS p = 0.03 ↑ 180 Mathews 2006 [26]
No difference in current tic severity p = 0.38 - 70 YGTSS Bos-Veneman 2010
[27]
No difference in worst ever tic severity p = 0.86 - 65 YGTSS Bos-Veneman 2010
[27]
No difference in tic severity NS - 110 YGTSS Bos-Veneman 2010
[27]
No difference in obsessive compulsive
severity





















Table 3 Pre and perinatal factors associated with tic severity and severity of co-morbid ADHD, OCD, and other disorders (Continued)
No difference in social behaviours other than
orientation ratings
NS - 110 CSBQ Bos-Veneman 2010
[27]
No difference in anxiety and total scale of
RCADS
NS - 110 RCADS Bos-Veneman 2010
[27]
Maternal alcohol drinking No difference in current tic severity p = 0.13 - 70 YGTSS Bos-Veneman 2010
[27]
No difference in worst ever tic severity p = 0.10 - 70 YGTSS Bos-Veneman 2010
[27]
No difference in ADHD severity p = 0.71 - 65 ADHD rating scale Bos-Veneman 2010
[27]




Delivery complications Worst ever YGTSS 28.7+/−9.1 vs. 23.4+/−7.3 p = 0.01 ↑ 70 YGTSS Bos-Veneman 2010
[27]
Associated with lesser total YGTSS ratings
after adjusting for age and gender modified
by DRD4 3R allele
p = 0.02 ↓ 110 YGTSS Bos-Veneman 2010
[27]
Associated with higher total anxiety ratings
and total RCADS after adjusting for age and
gender modified by DRD4 2R allele
p = 0.004 and
0.006
↑ 110 RCADS Bos-Veneman 2010
[27]
No difference in current tic severity p = 0.82 - 70 YGTSS Bos-Veneman 2010
[27]
No difference in ADHD severity P = 0.13 - 65 ADHD rating scale Bos-Veneman 2010
[27]
No difference in tic severity NS - 110 YGTSS Bos-Veneman 2010
[27]
No difference in obsessive compulsive
severity
NS - 110 CYBOCS Bos-Veneman 2010
[27]
No difference in social behaviours NS - 110 CSBQ Bos-Veneman 2010
[27]
No difference in anxiety and depression NS - 110 RCADS Bos-Veneman 2010
[27]
Delivery complications and other perinatal
adversities
No difference in tic severity between TS
twins
NS - 13 pairs Shapiro scales Hyde 1992 [25]



























Table 3 Pre and perinatal factors associated with tic severity and severity f co-morbid ADHD, OCD, and other disorders (Continued)
Neonatal factors
Birth Weight Higher tic scores in lighter body weight
twin on both Shapiro and YGTSS scales
p = 0.001 and
0.01
↓ 13 pairs Shapiro scales and
YGTSS
Hyde 1992 [25]
Within-pair body weight difference is
correlated with within-pair tic score
difference (rho = 0.72)
p < 0.005 ↓ 13 pairs Shapiro scale Hyde 1992 [25]
Birth order in TS twins Mean first-born tic score vs. mean
second-born tic score: 7.1 + −6.5 vs.
8.4 + −5.6
p = 0.57 - 8 pairs Shapiro scales and
YGTSS
Hyde 1992 [25]
Handedness in TS twins Tic score in right-handed vs. left-handed:
10.6 + −4.7 vs. 6.1 + −4.6




First-week postnatal complications No difference in current tic severity p = 0.87 - 69 YGTSS Bos-Veneman 2010
[27]
No difference in worst ever tic severity p = 0.74 - 69 YGTSS Bos-Veneman 2010
[27]
No difference in ADHD severity p = 0.83 - 64 ADHD rating scale Bos-Veneman 2010
[27]
ADHD: Attention Deficit Hyperactive disorder; C-GAS: Children's Global Severity Scale; CI: confidence terval; CSBQ: Children's Social Behavior Questionnaire; CYBOCS: Children's Yale-Brown Obsessive-Compulsive scale;
DRD4: Dopamine receptor D4; MDD; Major Depression Disorder; NS: non-significant; OCD: Obsessive ompulsive Disorder; OCS: Obsessive-Compulsive Symptoms; OR: odds ratio; RCADS: Revised Child Anxiety and
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for symptoms of ADHD in individuals with TS [26].
In addition to the prenatal factors mentioned above,
some studies have investigated the association of tic sever-
ity or comorbidity severity with maternal smoking, mater-
nal alcohol use, psychological stress during pregnancy, and
the overall number of prenatal problems (Table 3). More
severe ADHD rating scale scores, measured with the par-
ent version of the ADHD Rating Scale, were associated
with maternal smoking (smoking versus non-smoking:
26.4 ± 10.1 versus 19.1 ± 10.9, p = 0.05) [27]. This associ-
ation was more prominent when there was a positive fam-
ily history of mental disorders (p = 0.04) [27]. In another
study, higher depression and autism scale scores, mea-
sured with the major depressive disorder subscale of the
revised Child Anxiety and Depression Scale (RCADS) and
the parent version of the Children’s Social Behaviour
Questionnaire (CSBQ), were noted in TS patients with a
history of exposure to maternal smoking [28]. Maternal
smoking was also reported to be associated with greater
worst ever lifetime tic severity as measured by the YGTSS,
and more obsessive compulsive symptoms in another
study [26]. These results suggest an association between
maternal smoking and tic, ADHD and OCD severity in
individuals with TS. In addition to maternal smoking,
maternal psychological stress was noted to be associated
with greater tic severity [24]. With regard to the pre-
natal alcohol exposure, there was no association be-
tween maternal alcohol use and tic severity or ADHD
comorbidity [27].Perinatal factors
The presence of delivery complications including
meconium-stained amniotic fluid, premature rupture of
the membranes, nuchal cord, fetal bradycardia, placenta
praevia, or artificial delivery was reported to be associated
with higher worst ever tic severity (presence versus ab-
sence: 28.7 ± 9.1 vs. 23.4 ± 7.3, p = 0.01) as measured by
the YGTSS [27].
Dopaminergic genes are candidate genes in TS studies
given that alterations in dopaminergic neurotransmission
are believed to contribute to the etiology of tics. In a study
investigating the interaction between the dopamine recep-
tor D4 (DRD4) gene and perinatal factors associated with
tic severity, TS patients with the DRD4 3R allele and a his-
tory of delivery complications had a lower total tic scale
rating, measured with the YGTSS, compared to individuals
without the DRD4 3R allele (p = 0.02) [28]. The same study
also found that in patients with the DRD4 2R allele, higher
total anxiety ratings and total Revised Child Anxiety and
Depression Scale scores (RCADS) were noted in TS pa-
tients with delivery complications (p = 0.004 and 0.006 re-
spectively). These results suggest an interaction of geneticand environmental factors on the severity of tics and asso-
ciated comorbidities in TS patients.
Neonatal factors
In a twin study evaluating birth weight and lifetime tic se-
verity, the twin with lower birth weight had higher tic
scores measured with Shapiro Symptom Check List and
YGTSS [25]. In the same study, the within-pair body
weight difference was linearly correlated with the within-
pair tic score difference measured with the Shapiro score
(rho = 0.72, p < 0.005) [25]. These findings suggested that
lower birth weights were associated with the greater tic
severity between identical twins. In addition, these asso-
ciations had a linear dose–response relationship. These re-
sults suggest that lower birth weight is associated with
higher tic scores in TS patients.
Time trends and seasonal variation
There was one article investigating time trends in the in-
cidence of Tourette syndrome in a population-based co-
hort [30]. In this study, a statistically significant increase
was found in the cumulative incidence across specific
birth years for TS from 1990 to 1995. For example, for
children age 9, the cumulative incidences are 2.3 (95%
CI: 1.4-3.1), 2.4 (95% CI: 1.5-3.2), and 3.9 (95% CI: 2.9-
4.9) for birth cohort in 1990–1991, 1992–1993, and
1994–1995, respectively. The study could not identify if
there were environmental factors including pre- or peri-
natal adversities associated with this increase in incidence,
or whether this was due to an improvement in identifica-
tion and diagnosis of tic disorders over this time period.
Another study was performed using the same cohort data
to evaluate the seasonal variation in the incidence of TS.
The results found that there was no evidence of seasonal
variation of birth and TS incidence [29].
Other types of studies
Some indirect evidence also suggests that perinatal diffi-
culties may play a role in the onset of TS. In one study in-
vestigating TS probands and relatives’ risks for TS,
perinatal difficulties in TS probands were inversely related
to the recurrence risk among first-degree relatives of TS
probands [36]. This suggests that TS probands with peri-
natal problems had a lower risk of TS in first degree rela-
tives. It provides indirect evidence that part of the risk for
TS in these probands was related to these perinatal insults.
In another study investigating the association between
neonatal cranial ultrasound abnormalities and the preva-
lence of tic disorders in low-birth-weight children, the
prevalence of tic disorders at age of 6 was significantly as-
sociated with parenchymal lesions and/or ventricular en-
largement in neonatal cranial ultrasound examinations
(OR = 8.7, 95% CI: 1.3-57.7, p = 0.02) [39]. These results
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for the onset of tic disorders.
Discussion
Overall, there were few articles investigating the associ-
ation between pre- and perinatal adversities and the on-
set and severity of TS, and the presence and severity of
comorbid disorders. Although some studies have re-
ported associations between pre- and perinatal factors
and TS, many of the results are inconsistent. Taken as a
whole, there is only very weak evidence to support that
pre- and perinatal adversity are associated with the de-
velopment of TS, TS symptom severity and the presence
or severity of comorbidities.
One of the major issues regarding the available litera-
ture on the relationship between TS and pre and peri-
natal risk factors is the overall poor methodological
quality of the studies performed to date. Only five stud-
ies evaluated data on perinatal events that was collected
prospectively on registered birth certificates or as part of
a birth registry. The majority of studies used clinically
ascertained samples of individuals with TS, which may
differ substantially in disease severity than those ascer-
tained through population based means. The available
data are therefore susceptible to bias.
In comparing the results of the case control studies
using birth certificate data with those who ascertained in-
formation about perinatal events from mothers retrospect-
ively, there is no clear difference in the strength of
association between TS and various perinatal risk factors.
Burd [11] reported significantly earlier prenatal care, more
prenatal visits, a lower odds of having care begun after the
first trimester (three highly related factors), and lower
Apgar scores at 5 minutes among cases than controls.
Pasamanick [18] did not detect any significant relation-
ships between abnormalities during the pre or perinatal
period and TS.
Of the five studies examining the relationship between
perinatal adversity and TS and comorbidity symptom se-
verity, the majority of positive results reported would
not remain significant after appropriate statistical cor-
rection for multiple hypothesis testing. The exception is
the finding reported by Matthews [26] of the association
between increased global tic severity and the number of
medications reported in utero and maternal smoking
(both p < 0.00001).
Of all the risk factors studied, maternal smoking and low
birth weight appear to be the only risk factor with consist-
ent significant associations. Maternal smoking was re-
ported to be associated with the presence of comorbid
ADHD and OCD, and TS, ADHD and OCD symptom se-
verity. Although these results suggest a connection be-
tween maternal smoking and the onset of TS, other factors
linking these exposures to TS need to be considered.Nicotine has a therapeutic effect for some TS and ADHD
patients [41-46]. Nicotine has been shown to reduce com-
plex tics and improve behaviours related to inattention in
TS patients [41]. Individuals with ADHD have a higher
risk of smoking and nicotine dependence from adoles-
cence to young adulthood [47]. If mothers with tics or
ADHD smoke, the association of maternal smoking and
TS in the offspring might be due to heritability of these
disorders rather than smoking itself. Many individuals are
unaware of their tics and are never diagnosed with TS and
therefore may deny a family history of the disorder. This
confounding effect should be carefully examined in future
studies to clarify the association of prenatal smoking ex-
posure and the onset or severity of TS, and the presence
and severity of comorbid ADHD and OCD.
Most studies did not report significant associated neo-
natal factors with TS, except for low birth weight. Low
birth weight was found to be associated with comorbid
ADHD and tic severity. Low birth weight may be an in-
dependent factor associated with TS or comorbidities, or
may be a consequence of prenatal adversity. Although
this effect would be minimized in twin studies, further
investigations are necessary to identify whether low birth
weight itself is associated with TS or if it is the proxy of
other prenatal insults.
The limitations of this systematic review include the
overall poor methodological quality of the included stud-
ies, with differing study designs and analytic methods, and
extreme diversity of measurements among different stud-
ies. Definitions of prenatal or perinatal adversities differed
between studies, and were most commonly retrospectively
ascertained. Finally, as the clinical symptoms of TS wax
and wane during the disease course, the measurement of
tic severity at a single point of time does not truly repre-
sent disease severity for patients. Although it is difficult to
draw a valid conclusion from this literature, many pre-
and perinatal adversities were reported to be associated
with the onset of TS, the presence of comorbidities, and
the severity of tics and comorbidities. Future studies are
likely to make a significant contribution, especially if they
include population derived cohorts, use data on perinatal
events that was obtained prospectively, and use methods
to control for multiple hypothesis testing. Standards for
defining pre and perinatal events should be adhered to,
and TS symptom severity should be measured at multiple
time points if this outcome is being considered.
The mechanism through which prenatal and perinatal
events lead to TS onset or worsening tic severity is un-
known. These factors could contribute to microscopic
abnormalities in brain structure or function that lead to
the development of tics. TS is a neurodevelopmental dis-
order which shares common features with autism and
attention deficit hyperactivity disorder. Dysfunction of
the dopaminergic system has been implicated in all three
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prenatal stress may cause changes in the dopaminergic
system [48-51]. The frequent comorbidity of these neu-
rodevelopmental disorders in clinical practice suggests a
common pathophysiological basis, with shared prenatal
and perinatal risk factors in autism and ADHD support-
ing these relationships [52-54].
Conclusions
In conclusion, this systematic review provides weak evi-
dence for an association between pre- and perinatal ad-
versity and the onset of TS, comorbid disorders, and the
severity of tics, ADHD and OCD symptoms. Of all the
risk factors studied, maternal smoking and low birth
weight appear to be most consistently implicated. Stud-
ies of higher methodological quality are needed in order
to better understand the relationship between prenatal
and perinatal events and TS.
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